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In the nematode, C. elegans, the divergent GATA-type transcription factors MED-1 and MED-2 are encoded by an unlinked, redundant pair of
intronless genes. The med-1,2 genes are among the first to be activated in the embryo and are critical for the specification of the 7-cell stage MS
(mesoderm) and E (endoderm) precursor cells. We have previously shown that the binding site recognized by MED-1 is a noncanonical
RAGTATAC site that is not expected from the resemblance of its single C4-type zinc finger to those of other known GATA factors, which
recognize the consensus HGATAR. To date, no MED-like zinc fingers have been described outside of C. elegans. In order to understand the
evolution of these transcription factors, and the evolution of gene networks that specify early cell fates in Caenorhabditis, we have identified med
sequence homologs in the related nematodes C. briggsae and C. remanei. While C. briggsae encodes two med-like genes similar to C. elegans,
we find evidence for seven distinct med-like genes in C. remanei. Somewhat unexpectedly, the coding regions of all med genes appear to lack
introns. We report that the med homologs have similar expression in their respective species. We further show that the C. briggsae homologs, and
at least five of the seven C. remanei homologs, can fully complement the embryonic lethal phenotype of a C. elegans med-1,2() strain. We
conclude that Med function and expression have been conserved over tens of millions of years of evolution, and that there may be a mechanism
that selects against the acquisition of introns in these genes.
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Deployment of appropriate gene regulatory networks is the
means by which different cells acquire different fates during
metazoan development (Levine and Davidson, 2005). Gene
comparison among closely-related species is one method that
can be used to learn more about such networks, as conserved
features can reveal fundamental properties that change very
little over evolutionary time (Yuh et al., 2002). Such studies
contribute to our understanding of how the generation of
diversity among metazoans is related to changes in the
interactions among genes.
We are interested in the evolution of the gene regulatory
network that operates in mesendoderm specification in
Caenorhabditis. At the 7-cell stage of embryonic development
in C. elegans, the precursor cells MS and E are born (Sulston et0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.10.024
* Corresponding author. Fax: +1 951 827 4286.
E-mail address: mmaduro@citrus.ucr.edu (M.F. Maduro).al., 1983). The E cell clonally establishes the entire intestine
(midgut), which consists of 20 cells at hatching, while its sister
cell, MS, generates 80 cells that are primarily mesodermal in
character, including body wall muscle and cells of the posterior
half of the feeding organ, the pharynx.
The transcriptional regulatory cascade that controls specifi-
cation of MS and E in C. elegans is well understood (Fig. 1)
(Maduro and Rothman, 2002). The maternal gene skn-1
encodes a bZIP/homeodomain transcription factor required to
specify MS and E: loss of skn-1 function results in a
transformation of both MS and E into the mesectodermal
precursor C, which makes body wall muscle and hypodermis
(Bowerman et al., 1992). In the mother of MS and E, called
EMS, SKN-1 activates the expression of the med-1 and med-2
genes (Bowerman et al., 1993; Maduro et al., 2001). Depletion
of med-1,2 by RNAi also results in a transformation of MS and
E to C, although E is correctly specified in approximately half
of mutant embryos (Maduro et al., 2001). In the E cell, MED-
1,2 activate the genes end-1 and end-3, which encode a pair of89 (2006) 444 – 455
www.e
Fig. 1. Simplified representation of the regulatory cascade specifying MS and E
in C. elegans. Diagrams of a 4-cell and 8-cell embryo are shown for reference.
The maternal SKN-1 transcription factor activates zygotic expression of med-1
and med-2 in EMS (Maduro et al., 2001). In turn, MED-1,2 activate target
genes in MS and E to specify their fates. In the E cell, MED-1,2 activate end-
1,3 to specify an endodermal fate (Maduro et al., 2002). The Wnt effector POP-
1 is a coregulator along with the MEDs: in MS, POP-1 represses end-1,3, while
in the E cell, the repressive activity of POP-1 is blocked as a result of the Wnt
signaling event that polarizes EMS at the 4-cell stage (Goldstein, 1992; Maduro
et al., 2002; Rocheleau et al., 1997; Thorpe et al., 1997). In E, POP-1 and PAL-
1 also function as end-1,3 activators in parallel with the MEDs (Maduro and
Rothman, 2002; Maduro et al., 2005b). MS gives rise to primarily mesodermal
cell types, including body wall muscle and the posterior half of the pharynx.
The E cell clonally establishes the entire midgut (intestine). Sister cells are
joined by a short line, and the nuclei of EMS, MS, and E are shaded black. In
this and other figures, embryos are shown with anterior to the left and dorsal up.
Table 1
Rescue of a C. elegans med-1,2() mutant with med homolog transgenes
Strain(s) Transgene Rescuea Viable Arrested embryo Total
With gut Without
gut
MS247 Noneb n/a 0% (0) 58% (70) 42% (50) 120
MS290, MS291 Ce-med-1 Yes 97% (203) 1% (3) 1% (3) 209
MS402, MS403 Ce-med-2 Yes 98% (353) 2% (6) 0% (1) 360
MS298, MS299 Cb-med-1 Yes 80% (237) 18% (53) 3% (8) 298
MS420 Cb-med-2 Yes 33% (14) 57% (24) 10% (4) 42
MS293, MS295 Cr-med-1 Yes 76% (148) 24% (46) 0% (0) 194
MS335, MS336 Cr-med-2 No 0% (0) 61% (57) 39% (37) 94
MS314, MS315 Cr-med-3 Yes 86% (128) 13% (19) 1% (2) 149
MS317, MS393 Cr-med-4 Yes 64% (319) 35% (176) 1% (7) 502
MS319, MS320 Cr-med-5 Yes 87% (290) 11% (38) 2% (5) 333
MS322, MS323 Cr-med-6 Yes 93% (169) 6% (11) 1% (2) 182
MS337, MS338 Cr-med-7 No 0% (0) 90% (53) 10% (6) 59
a MS247 [med-1(ok804); med-2(cx9744); irDp1] animals were made
transgenic for a plasmid or PCR product containing the indicated gene and
an unc-119::CFP reporter. Lines that could be propagated in the absence of the
irDp1 balancer were considered to be rescued. For those that did not rescue,
lines were constructed that also contained the rol-6D marker plasmid (pRF4) to
facilitate maintenance of the transgenes. Only animals expressing unc-
119::CFP (indicative of the test array) but not unc-119::YFP (indicative of
irDp1) were scored. For those genes that rescued, only unc-119::CFP embryos
were scored.
b Non-irDp1 MS247 segregants (i.e., embryos lacking unc-119::YFP) were
scored. n/a, not applicable.
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Rothman, 2002; Maduro et al., 2005a). In the MS cell, the
corepressor POP-1 blocks the ability of MED-1,2 to activate
end-1,3, allowing the meds to promote a mesodermal fate
(Maduro et al., 2002). The repressive function of POP-1 is
blocked in the E cell by transduction of a Wnt/MAPK/Src
signal that originates from a cell–cell interaction between EMS
and its sister cell, P2 (Bei et al., 2002; Goldstein, 1992;
Rocheleau et al., 1997, 1999; Shin et al., 1999; Thorpe et al.,
1997). POP-1 then functions as an activator, and along with the
Caudal-like protein PAL-1, also contributes to E specification
in parallel with med-1,2 (Maduro et al., 2005b). The med-1 and
med-2 genes therefore play a critical role in the specification of
the MS and E progenitors, as they function at the interface of
SKN-1 activation and transduction of a signal initiated by the
P2–EMS interaction.
The med-1 and med-2 genes encode nearly-identical single
C4 zinc finger proteins with similarity to the GATA family of
transcription factors, which recognize the canonical binding
site HGATAR (Lowry and Atchley, 2000; Maduro et al., 2001).
MED-1 (and presumably MED-2, whose DNA-binding domain
differs by only a single amino acid) recognizes RAGTATAC
sites, suggesting that MED-1,2 have diverged in function from
the GATA family (Broitman-Maduro et al., 2005). No proteins
similar to MED-1 are known to exist outside of Caenorhabditis
that are not themselves more similar to canonical GATA
factors, suggesting that they may be a nematode invention.Because of the uniqueness of the MEDs among eukaryotic
regulators, little is known of their evolutionary origin, and
structure– function properties of the MED DNA-binding
domain have yet to be elucidated.
In order to expand the collection of known MED-like
regulators, and as first step toward studying the mesendoderm
gene network in other species, we have mined the genome
sequences of the related nematodes, C. briggsae (a hermaphro-
ditic species) and C. remanei (a male–female species). C.
remanei and C. briggsae are more closely related to each other
than C. elegans is from either (Cho et al., 2004; Kiontke et al.,
2004). By some estimates, C. elegans is 80–110 million years
diverged from the last common ancestor to C. briggsae, and
hence C. remanei (Coghlan andWolfe, 2002; Stein et al., 2003).
In this study, we compare the structure and genome organization
of the med homologs from C. briggsae (two med genes) and C.
remanei (seven med genes), and provide evidence that their
expression and function have been conserved.
Materials and methods
Strains and genetics
The following strains were used in this work: PB4641 (wild-type C.
remanei strain), AF16 (wild-type C. briggsae), N2 (wild-type C. elegans),
MS240 [unc-119(ed4) III; irEx102[unc-119(+), pMM808]], MS247 [med-
1(ok804) X; med-2(cx9744) III; irDp1(III;f)]. Transgenic strains used to test
rescue are listed in Table 1. The free duplication irDp1 (carried by MS247) was
derived from the free duplication sDp3, which carries a single copy of med-2,
after spontaneous integration of an array (irEx14) consisting of the Ce-med-1
plasmid pMM277, the unc-32-rescuing plasmid pAIE5 (Pujol et al., 2001), and
an unc-119::YFP reporter plasmid (pMM531). A more detailed description of
the properties of MS247 will appear elsewhere.
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The C. briggsae med homologs correspond to CBG18154 (Cb-med-1) and
CBG18155 (Cb-med-2) in WormBase (http://www.wormbase.org, release
WS140). To identify candidate med genes from C. remanei, we used a
TBLASTN search of the preliminary genome assembly of C. remanei (as of 7/
29/2004) with Ce-MED-1 using the Washington University BLAST server
(http://www.genome.wustl.edu/blast/client.pl). Sequences were extended in the
5V and 3V directions by correlating the aligned segment pairs to the sequence
files downloaded from the Washington University server (ftp://www.genome.
wustl.edu/pub/seqmgr/remanei/plasmid_assembly/). Gene sequences were
compiled, annotated, and analyzed using Vector NTI 6 (Informax) on a Dell
PC. The Accession numbers for the Cr-med genes are as follows: Cr-med-1, -2,
and -3, DQ288162; Cr-med-4 and -5, DQ288163; Cr-med-6, DQ288164; and
Cr-med-7, DQ288165.
RNA interference (RNAi)
For RNAi experiments, double-stranded RNA (dsRNA) was synthesized
using the T7 MEGAscript kit (Ambion) from a PCR product containing the Cr-
med-1, Cr-med-3, or GFP coding regions tagged with the T7 RNA polymerase
recognition sequence on both ends. dsRNA at 4 Ag/AL was injected into both
gonad arms of C. remanei females as was described for C. elegans
hermaphrodites (Fire et al., 1998). Depletion of skn-1 for testing the Cr-med-
1::GFP translational fusion strain MS240 was performed by placing L2 animals
on E. coli HT115 bacteria induced to accumulate skn-1 dsRNA (Montgomery,
2004), and scoring progeny embryos in the uterus of these animals 3 days later.
All RNAi experiments were performed at 20-C.
Transgenic C. elegans strains and plasmid construction
Transgenic animals were generated as described (Mello et al., 1991). TheCr-
med-1::GFP::MED-1 fusion pMM808 was constructed as follows. The Cr-med-
1 promoter and coding region/3VUTRwere sequentially cloned into a pBluescript
KS(-) backbone as separate PCR products amplified from PB4641 genomic
DNA.An open-endedGFP cassette, amplified from vector pPD95.67 (a gift from
Andrew Fire, Stanford University), was inserted at the join between these
segments. PCR and cloning were performed according to standard protocols;
oligonucleotide sequences and cloning details are available upon request.
For rescue assays, plasmids carrying Ce-med-1 (pMM277), Ce-med-2
(pMM493),Cb-med-1 (pMM556), andCr-med-1 (pMM807), and PCR products
carrying the remaining Cr-med genes were generated containing ¨0.5 kbp–1
kbp 5V to the coding region and ¨0.3 kbp 3V sequence. Plasmid DNA (50–100
ng/AL) or gel-purified PCR products (20 ng/AL) were coinjected with unc-
119::CFP (pMM809) into MS247. Lines that carried unc-119::CFP but lacked
unc-119::YFP (indicative of irDp1) were identified using appropriate filter sets
(Miller et al., 1999) on a Leica dissecting microscope. The absence of irDp1
could also be confirmed because these strains lacked an adult egg-laying defect
associated with irDp1. Thereafter, rescued lines were self-maintaining, and
transgenic embryos could be scored by pan-neuronal unc-119::CFP expression
from midembryogenesis to adulthood (Maduro and Pilgrim, 1995). For Cr-med-
2 and Cr-med-7, which did not rescue, lines were made in which the arrays were
also marked with rol-6D (Mello et al., 1991). PCR confirmed the presence of Cr-
med-2 and Cr-med-7 in these strains.
In situ hybridization
Detection of med transcripts in whole-mount embryo preparations was
performed essentially as described (Seydoux and Fire, 1995), except that
embryos were fixed using Streck Tissue Fixative (STF; Streck Laboratories,
Inc.) and antisense RNA probes were used. A more detailed protocol will
appear elsewhere.
RT-PCR analysis
Embryos were obtained from C. remanei females by bleaching. After
homogenization in Trizol (Invitrogen), total RNA was purified from theaqueous phase using the Qiagen RNeasy Kit according to the manufacturer’s
instructions. Residual genomic DNA was removed by treatment with DNaseI
(Ambion). First-strand and PCR primers were designed to target specific Cr-
med genes. Superscript II Reverse Transcriptase (Invitrogen) was used
according to the manufacturer’s instructions, except that 0.5 AL of T4gp32
(USB) was added to the RT reactions in 10 AL total volume.
Results
C. elegans and C. briggsae have two med genes, while C.
remanei has seven
In C. elegans, the med-1 and med-2 genes are found on
separate chromosomes (Fig. 2) (Maduro et al., 2001). In C.
briggsae, there are two med-like genes found within 2 kbp of
each other in an inverted orientation. In both C. elegans and C.
briggsae, the intraspecific MED paralogs are nearly identical
(98% for Ce-MED-1/2 and 97% for Cb-MED-1/2), while Ce-
MED-1 and Cb-MED-1 are only 29% identical overall,
consistent with recent duplication. We used the sequence of
C. elegans MED-1 to search contigs from the preliminary
genome assembly of C. remanei. Using the TBLASTN
algorithm (Altschul et al., 1990), seven distinct coding regions
were identified (Figs. 2 and 3). Like their C. elegans and C.
briggsae counterparts, all seven Cr-med genes appear to lack
introns, as we could find no good candidate splice donor and
acceptor sites similar to those used in C. elegans (Blumenthal
and Steward, 1997). The conservation of amino acids and lack
of in-frame stop codons across the coding regions further
support an intronless structure (Fig. 3). Putative polyadenyla-
tion sites (AATAAA) occur within 73–108 base pairs
downstream of predicted Cb-meds and Cr-meds (Fig. 2). The
C. remanei med genes display a combination of linked and
unlinked duplications: Cr-med-1, -2, and -3 are located within
5 kbp of each other, while Cr-med-4 and -5 appear in adjacent,
parallel orientation within 2 kbp (Fig. 2). The remaining genes,
Cr-med-6 and Cr-med-7, appear on separate contigs. As these
identifications were based on a preliminary sequence assembly,
further synteny among all the Cr-med genes, and the existence
of additional med paralogs, cannot be ruled out.
Most of the Cr-med genes encode proteins of a similar size
(164–197aa), while Cr-med-2 contains a 5V truncated coding
region and is predicted to encode a 93-aa polypeptide that
includes the DNA-binding domain (Figs. 2 and 3). An
inspection of the protein alignments (Fig. 3) and a phylogenetic
tree generated from their DNA-binding domains (Fig. 4C)
strongly suggest that the intraspecific med duplications arose
from a single ancestral gene by duplication. Hence, the
formation and retention of new med paralogs in Caenorhabdi-
tis appear to be a common occurrence for this gene family.
Conserved structural features of the MED class of GATA
factors
The Ce-MED proteins contain a single C4-type zinc finger
and basic domain which recognize a non-GATA consensus
sequence (Broitman-Maduro et al., 2005). By alignment with
GATA DNA-binding domains whose solution structures have
Fig. 2. The arrangement of med genes in C. elegans, C. briggsae, and C. remanei. SKN-1 sites (lollipops) and poly-A sites (diamonds) are shown above the DNA if
they occur on the top strand and below the DNA if they occur on the complementary strand. The coding regions for the med genes are shown as shaded rectangles,
with the C4 zinc fingers indicated by darker shading.
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differences at positions known to make base-specific contacts
(Broitman-Maduro et al., 2005; Omichinski et al., 1993; Starich
et al., 1998). We examined the entire suite of 11 MED-like
coding regions to identify amino acids that may define this
divergent GATA subtype. An alignment of the predicted DNA-
binding domains of the C. elegans and C. remanei MEDs, as
well as those of other GATA factors, reveals structural
similarities (Fig. 4A). First, the MED zinc fingers all include
an extra amino acid between the cysteine pairs: The fungal AreA,
chicken cGATA-1, and C. elegans ELT-1 and ELT-3 GATA
factors contain 17 residues between the 2nd and 3rd cysteines,
while all of the MED proteins contain 18, raising the intriguing
possibility that the additional amino acid accounts for the
GTATA core of the MED binding site. Second, we can identify
nine amino acids that occur among all MED proteins, but which
do not occur in other GATA factors (indicated by asterisks in Fig.
4A). Although the functional significance of these amino acids is
not yet known, their high degree of conservation suggests that at
least some of them may mediate protein–DNA interactions that
determine MED binding specificity. Finally, a phylogenetic tree
generated from the alignment shown in Fig. 4A validates the
notion that the MEDs do indeed form a distinct subgroup of
GATA factors (Fig. 4B).5V flanking gene sequences predict similar expression of
Cr-med genes
In addition to similar coding regions as their C. elegans
counterparts, the Cb-med and Cr-med genes display multiple
recognition sequences for the SKN-1 transcription factor in the
5V flanking sequence (Fig. 2). SKN-1 has structural features
found in both bZIP and homeodomain transcription factors, and
its core binding site has been determined as RTCAT (Blackwell
et al., 1994). Of the known direct SKN-1 targets in C. elegans,
regulation by SKN-1 in vivo appears to require clusters of SKN-
1 sites in close proximity (An and Blackwell, 2003; Maduro et
al., 2001). Both C. elegans med genes contain clusters of SKN-1
sites ¨90 bp upstream of the start codon. These sites mediate
binding by SKN-1 in vitro and are required for activation of a
med-1 reporter gene in vivo (Maduro et al., 2001). For both Cb-
med genes, and five of the seven Cr-med genes, there are at least
six SKN-1 sites within the 250 bp directly upstream of the
predicted start codon. As this is expected to occur by chance in
less than 0.5% of all DNA segments of similar size and base
composition, the presence of these sites suggests that they have
undergone positive selection. The occurrence of multiple SKN-1
sites in the Cb-med and Cr-med genes, therefore, suggests that
most of them are direct targets of a SKN-1-like activator. Two of
Fig. 3. Alignment of all known MED proteins. White text on a black background indicates identities with Cr-MED-1, while black text on a gray background
indicates a conservative change as defined by the BLOSUM62mt2 matrix (Henikoff and Henikoff, 1992). Amino acid positions relative to the start codon are
indicated. For Cr-MED-2, an additional 14 codons specified upstream of the putative start codon have been included in the alignment. Asterisks indicate residues that
are conserved in all MED coding regions (excepting those in Cr-MED-2 that occur upstream of its putative start codon).
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not be expressed at high efficiency downstream of SKN-1.
While all other med genes except Cr-med-2 and Cr-med-7
contain overlapping SKN-1 sites of the form RTCATCAT (one
site underlined, the other overlapping site in italics), Cr-med-2
contains only a single SKN-1 site in its upstream region, and
while Cr-med-7 contains four SKN-1 sites in close proximity,
none of these is present in an overlapping fashion. Hence, there
is reason to suspect that Cr-med-2 and Cr-med-7 may not
efficiently recruit SKN-1 (discussed below).
Conservation of Cr-med expression
Embryonic development of C. remanei has not been
characterized in detail, but is superficially similar to that of C.elegans (Fig. 5). We therefore sought to determine if the
molecular basis for mesendoderm specification was also
conserved. Previous evidence suggested that Ce-med-1,2 are
transcribed at the 4-cell stage (Maduro et al., 2001). We
confirmed Ce-med-1,2 expression by in situ hybridization using
an antisense Ce-med-1 probe, which should detect both med
genes due to their high degree of nucleotide similarity (Maduro
et al., 2001). As expected, we detected nascent Ce-med mRNA
transcripts in the EMS nucleus (Fig. 6A). To determine whether
the Cr-med genes are similarly transcribed, we performed in situ
hybridization on early C. remanei embryos using an antisense
Cr-med-3 probe. As the Cr-med genes share several regions of
as high as 90% sequence identity (data not shown), this probe is
capable of detecting all seven putative Cr-med genes simulta-
neously. We observed strong signal in the C. remanei EMS
Fig. 4. Relatedness of the MED DNA binding domains to those of other GATA factors. (A) Alignment of DNA-binding domains (DBDs) of the MEDs, two other C.
elegans GATA factors (END-1 and ELT-1; sequences from Wormbase, http://www.wormbase.org), a fungal GATA factor (A. niger AreA; Accession number
CAA57524), and chicken GATA1 (Gg-GATA1; Accession number A32993). For the two-fingered proteins ELT-1 and GATA1, only the carboxyl finger (Cf) and
basic domain are shown. (B) Relatedness tree generated by AlignX (Vector NTI 6, ClustalW algorithm) from the alignment shown in panel A, showing that the MED
proteins form a subgroup diverged from other GATA factors. Note that this particular alignment (which includes only one MED DBD from each species) suggests
that the homologs of C. remanei and C. briggsae are more closely related to each other than to C. elegans MED-1, consistent with their apparent evolutionary
relationship (Cho et al., 2004; Kiontke et al., 2004). (C) In an alignment of the DBDs of all MEDs from all three species (rooted using Ce-END-1 and chicken
GATA-1 as outgroups, not shown), the Ce-MEDs are found to be more closely related to the Cr-MEDs than the Cb-MEDs, and support is found for a single ancestral
MED gene. The horizontal time scales in panels B and C are not identical.
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embryonic stages (not shown). In parallel experiments with Cb-
med-1, we observed expression in EMS in C. briggsae embryos
(data not shown). Therefore, at least onemed gene is transcribed
in EMS in C. remanei and C. briggsae. To evaluate whether
multipleC. remanei med genes are expressed, we performed RT-
PCR on early embryo RNA.We found evidence that at least five
of the Cr-med genes (Cr-med-1, -3, -5, -6, and -7) are expressed
(Fig. 6G). Taken with the result that we did not see in situ
hybridization outside the EMS cell, we conclude that at least five
of the C. remanei med genes are expressed in the early embryo.
We next evaluated the ability of a C. remanei med gene
reporter to express appropriately when introduced into C.
elegans. A C. elegans med-1::GFP::MED-1 fusion (pMM280)
expresses in the nucleus of E and MS and their daughters (Figs.
6B–C) (Maduro et al., 2001). We constructed a Cr-med-
1::GFP::MED-1 construct, pMM808. C. elegans embryos
transgenic for pMM808 as an extrachromosomal array (strain
MS240) display an expression pattern indistinguishable from
the C. elegans reporter (Figs. 6E, F). With both the C. elegans
and C. remanei fusions, no significant expression was observedoutside the early E and MS lineages (data not shown). In
similar experiments, C. elegans embryos transgenic for a C.
briggsae med-1::YFP fusion showed expression in the early
MS and E lineages (not shown).
As embryonic activation of Ce-med-1,2 is dependent on
activity of skn-1, we tested whether this was true of the Cr-
med-1 reporter expressed in C. elegans. Such dependence is
expected because of the presence of SKN-1 site clusters in the
Cr-med-1 promoter. Indeed, while 51% (n = 106) of untreated
MS240 embryos at the 8- to 16-cell stage express the Cr-med-1
reporter, expression was not detected in any similarly-staged
embryos (n = 122; P < 0.0001) when skn-1 was targeted by
RNAi. We conclude that like Ce-med-1, a Cr-med-1 reporter
transgene is activated in a SKN-1-dependent manner when
introduced into C. elegans.
Chromosomal Ce-med mutants show that the meds are
essential genes
RNA interference (RNAi) can be used to produce entire
broods of phenocopy mutants for many targeted genes (Fire et
Fig. 5. C. elegans and C. remanei undergo similar early embryonic
development. DIC images of living embryos were obtained at various stages.
Early cleavages are asymmetric and establish a similar appearance of the size
and position of early blastomeres at the 4-cell, 8-cell, and gastrula stages. At the
1.5-fold stage, a prominent basement membrane (bm) outlines the developing
digestive tract. At the 3-fold stage, the posterior pharynx (made by MS) can be
seen by the presence of the grinder (gr). Gut granules, as seen by polarized
light, are indicative of differentiated endoderm. C. elegans and C. remanei
embryos are approximately 50 Am along their long axis.
C. Coroian et al. / Developmental Biology 289 (2006) 444–455450al., 1998). RNAi targeted to Ce-med-1,2 produces a small
number of arrested embryos that show defects in MS and E
specification, along with many viable animals (Maduro et al.,
2001). As the only means used to assess med-1,2 function was
RNAi, an absolute requirement for med-1,2 function was not
proven, nor was there a good means of assessing the med
function of exogenous transgenes (i.e. by rescue). We
constructed a strain, MS247, that generates bona fide med-
1,2() mutant embryos. MS247 is homozygous for med-
1(ok804), a deletion removing the entire Ce-med-1 coding
region, and med-2(cx9744), an insertion of a heterologous
transposable element that is predicted to abrogate Ce-med-2
function (see Fig. 8) (Granger et al., 2004). The strain is
balanced by a large free duplication, irDp1, that provides med
function and expresses an unc-119::YFP marker that enables
identification of animals that have inherited it. All med-
1(ok804); med-2(cx9744) embryos made by MS247 undergo
embryonic arrest. These embryos lack posterior pharynx,which is made by MS, and a further 42% also lack endoderm
(Figs. 7A–D). In isolation, >95% of single med-1(ok804) or
med-2(cx9744) mutant embryos are completely viable. Hence,
the med genes together are indeed essential for embryogenesis
as originally proposed (Maduro et al., 2001), and the small
number of mutants that result from med-1,2(RNAi) results from
poor RNAi effectiveness with these genes.
We attempted to obtain Cr-med(RNAi) embryos by injecting
high concentrations of Cr-med-1 or Cr-med-3 dsRNA directly
into female gonad arms, which is expected to produce the
strongest possible RNAi effects (Fire et al., 1998; Maduro et
al., 2001; Montgomery, 2004). While several med-like progeny
(many of which appeared to also lack endoderm) were
observed, similar embryos were also found after injection of
control GFP dsRNA and even in untreated animals (data not
shown). The high background of arrested embryos (5–20%) in
our C. remanei strain, coupled with the apparent low efficacy
of RNAi targeted to the Cr-meds (as occurs in C. elegans),
leaves us unable to correlate a specific phenotype with loss of
Cr-med function.
Most of the Cr-med and Cb-med genes can substitute for
Ce-med-1,2
As another approach to evaluate the functional conservation
of the Cr-med genes, we tested the ability of the Cr-meds to
complement the C. elegans med-1,2() mutant strain. We
coinjected the Cr-med-1::GFP::MED-1 plasmid with the rol-
6D transformation marker (Mello et al., 1991) into MS247.
Among the progeny were Rol animals that had lost both
expression of the irDp1-associated unc-119::YFP marker, as
well as an adult egg-laying defect associated with irDp1,
suggesting that the rescuing function of irDp1 was now being
provided by an array containing Cr-med-1(+). Two lines were
obtained that appeared to have lost irDp1, and which produced
broods consisting of arrested Med embryos and viable embryos
(Figs. 7E–F) that developed into fertile adults. Using PCR, we
tested genomic DNA of one line (MS268) and confirmed that
irDp1 was no longer present (Fig. 8). This confirms that the
Cr-med-1::GFP::MED-1 transgene is able to rescue med-
1(ok804); med-2(cx9744) embryos to complete viability.
We next tested each of the med homologs for their ability to
complement the lethality of C. elegans med-1(ok804); med-
2(cx9744) embryos. For each homolog, plasmids or PCR
products containing each gene were coinjected with an unc-
119::CFP reporter into MS247. We note that as extrachromo-
somal arrays typically consist of many copies of the injected
DNA (Mello et al., 1991), this type of rescue assay is at best
semi-quantitative in nature. For all med homologs except Cr-
med-2 and Cr-med-7, we obtained lines that had lost the parent
irDp1 balancer and were now completely dependent upon the
transgene.
Using the cotransformed unc-119::CFP marker, which can
be detected at all stages after midembryogenesis, we quantified
the degree of rescue by scoring the proportion of array-carrying
animals that were restored to embryonic viability (Table 1). We
found that while 97–98% of embryos carrying Ce-med-1(+) or
Fig. 7. The function of the MEDs is conserved between C. elegans and C.
remanei. (A–D) C. elegans med-1(ok804); med-2(cx9744) mutant embryos,
which fail to elongate beyond 2-fold and lack posterior pharynx as seen by
Nomarski optics (A, C). 58% (n = 120) of med-1,2() mutants make
endoderm (arrowheads in panel B), while the remaining 42% do not (D) as
assayed by the presence of gut granules under polarized light. (E–F) C.
elegans med-1,2() embryo rescued by a Cr-med-1::GFP::MED-1 transgene
array. The animal has undergone complete elongation, posterior pharynx is
present as evidenced by the prominent grinder (gr), and endoderm is present
(arrowheads in panel J).
Fig. 6. Expression of C. elegans and C. remanei med genes is conserved. Top row: in situ hybridization of a 4-cell C. elegans embryo with a Ce-med-1 probe reveals
transcription in the nucleus of EMS (A). A C. elegans med-1::GFP::MED-1 translational fusion shows nuclear signal in the EMS daughters MS and E (B), and in
their daughters (C). Bottom row: in situ hybridization of a C. remanei embryo with a Cr-med-3 probe reveals transcription in the EMS nucleus (D). The nucleotide
sequence similarity among the C. remanei med paralogs predicts that this probe will detect all med mRNAs simultaneously. A translational Cr-med-1::GFP::MED-1
fusion, introduced into C. elegans, displays a similar pattern of activation in E and MS (E) and their daughters (F). (G) Gene-specific RT-PCR products from early C.
remanei embryos, showing detection of transcripts from five Cr-med genes (lanes marked F+_). Lanes corresponding to control reactions lacking reverse transcriptase
are shown as F_. Amplification was not observed for Cr-med-2 and Cr-med-4 (not shown).
C. Coroian et al. / Developmental Biology 289 (2006) 444–455 451Ce-med-2(+) were rescued, the proportion of fully-rescued
animals carrying an interspecific med transgene was generally
lower. For all homologs except Cr-med-2 and -7, a significant
fraction of transgenic embryos (between 7 and 67%) was
inviable. By Nomarski optics, many of these embryos
elongated beyond two-fold, but had apparent defects in the
morphology of the posterior pharynx, with some having only a
slightly irregular grinder (data not shown), suggesting that a
failure to completely specify MS (rather than E) accounts for
the lack of complete rescue. Indeed, endoderm was made by a
higher proportion of these arrested embryos (between 85% and
100%) than by arrested nontransgenic embryos (58%; P < 0.01
for all except Cr-med-6, which has a P = 0.07), consistent with
a greater ability of the med homologs to rescue the partial E
defect of med-1,2() embryos.
While the aforementioned med homologs rescued the vast
majority of transgenic embryos, Cb-med-2, Cr-med-2, and Cr-
med-7 showed marked differences in their abilities to
complement a C. elegans med-1,2() strain. First, while we
were able to obtain a single rescuing line for Cb-med-2, the
majority of transgenic embryos (67%) were inviable. This may
be due only to the line itself, as one line (MS317) for Cr-med-4
also showed 32% viability, while the other Cr-med-4 line
(MS393) showed 97% (the data in the table are pooled). Hence,
we can make no strong conclusion about Cb-med-2 function
other than it is capable of rescue. Second, the genes Cr-med-2
and Cr-med-7 were unable to rescue to viability. Among
arrested embryos, 61% (57/94) of med-1,2(); Ex[Cr-med-2]
embryos made endoderm, which is comparable to the 58% that
did so in nontransgenic med-1,2() embryos (P = 0.7). In
contrast, 90% (53/59) of med-1,2(); Ex[Cr-med-7] embryos
Fig. 8. A C. elegans med-1,2() strain rescued by Cr-med-1(+) carries no intact Ce-med gene. The ok804 allele of med-1 deletes 2.5 kbp of genomic DNA,
including the entire coding region and promoter of med-1, and contains a heterologous insertion of 0.8 kbp. The agarose gel shows results of PCR amplification of C.
elegans med-1 and med-2 wild-type and mutant alleles from MS247, a strain rescued by irDp1, and MS268, a strain in which irDp1 has been replaced by an
extrachromosomal array containing Cr-med-1(+). To the right of the gel, diagrams (approximately to scale) show the arrangement of PCR primers (arrows) relative
to the C. elegans med-1 and med-2 genes. The gray rectangles directly beneath the DNA show the med-1 or med-2 coding regions. For med-1(ok804), the
heterologous insertion is shown by a thicker black line between the deletion breakpoints. For med-2(cx9744), the heterologous Mos1 insertion (Granger et al., 2004)
is shown as a large gray rectangle.
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med-7 fail to rescue the MS specification defect, but where Cr-
med-2 also fails to rescue E specification, there is evidence that
Cr-med-7 can rescue E fate. Perhaps not surprisingly, these two
genes are the very ones whose promoters differ from the other
(rescuing) genes in that they lack clusters of overlapping SKN-
1 sites as discussed earlier. The presence of a conserved, intact
open reading frame in Cr-med-7, and its ability to complement
the endoderm defect, suggest that when introduced into C.
elegans, the Cr-MED-7 gene product is made from this gene
(perhaps at a low level) and that it has at least partial function.
In the case of Cr-med-2, the apparent amino truncation of the
Cr-MED-2 coding region, and its inability to rescue either the
MS or E defects in C. elegans, suggest that the transgene may
either not be expressed, or that the short Cr-MED-2 gene
product lacks an essential component of MED function.
Taken together with the expression data, we conclude that
gene activation and function of the med genes have been
conserved among C. elegans, C. briggsae, and C. remanei.
Discussion
In this study, we have shown that: (1) the C. remanei
genome encodes seven structural homologs of C. elegans med-
1; (2) the collective MED homologs predict functionally
important amino acids in the MED zinc finger and basic
domain; (3) expression of the C. remanei and C. elegans med
genes occurs in the EMS nucleus; (4) a Cr-med-1 translational
GFP fusion introduced into C. elegans confers med functionand similar expression as a C. elegans reporter; (5) five of the
seven C. remanei homologs can complement the embryonic
lethality associated with C. elegans embryos lacking med-1,2
function; (6) expression and function of the C. briggsae med
genes are similarly conserved. These results provide strong
evidence that specification of mesendoderm in these species
occurs by similar mechanisms.
Gene duplications among med genes are common
Comparison of the MED amino acid sequences suggests that
all intraspecific paralogs arose from a single ancestral gene.
The occurrence of seven highly similar Cr-med genes seems,
therefore, to represent an extreme case of redundancy arising
from gene duplication. In C. elegans and C. briggsae, the med
genes exist in only two copies. Many of the non-MED GATA
factors are also found in two to three paralogous copies
(Maduro and Rothman, 2002). Ce-end-1 and Ce-end-3 are
linked paralogs that function together to specify endoderm (E)
fate (Maduro and Rothman, 2002; Maduro et al., 2005a). In C.
briggsae, there is a single Cb-end-1 homolog and two Cb-end-
3 homologs (Maduro et al., 2005a). Within C. elegans, other
paralogous pairs are known: Ce-elt-2 and Ce-elt-7 (Maduro
and Rothman, 2002) and Ce-egl-18 and Ce-elt-6 (Koh and
Rothman, 2001). Our preliminary examination of the C.
remanei genome sequence suggests that with the exception
of the meds, a possible duplicate of elt-1, and the absence of
the small elt-4 gene, the remaining six C. elegans GATA
factors (Ce-elt-2, Ce-elt-3, Ce-egl-18, Ce-elt-6, Ce-end-1, and
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remanei (data not shown).
Why might so many copies of C. remanei med genes have
been maintained through evolution? One hypothesis is that
these genes are in the process of acquiring new, essential
functions that have caused the duplicated copies to be retained.
However, the high degree of sequence relatedness, both within
and outside the coding regions, suggests that most of the Cr-
med genes share similar expression and function, as they are
clearly recent duplicates. That the Cr-med genes have retained
similar activity is substantiated by the ability of most to
complement a C. elegans strain lacking endogenous med
function. We did not detect med expression in postgastrulation
C. remanei embryos, nor in similar C. elegans embryos
expressing a Cr-med-1 reporter, suggesting that the Cr-meds
function only in MS and E specification. However, we cannot
rule out additional functions of the Cr-MED proteins or
postembryonic expression.
An alternative explanation is that the med genes have been
maintained by a mechanism that selects for their additive
contribution to a single function. If a threshold level of Med
activity is critical for robust MS and E specification, gene
duplication might have arisen as a means of compensating for
decreased activation of individual med genes. If the mechanism
that activates the meds became compromised in an ancestral
species (e.g. from a reduction in number of SKN-1 sites in a
single ancestral med gene), this might create a strong selection
for additional Med activity arising from gene amplification. At
least in C. elegans, the limiting step in med activation is not
SKN-1 activity: in situ hybridization of embryos carrying a
multicopy Ce-med-1 transgene displays manyfold higher
accumulation of med mRNA than wild-types (not shown),
suggesting that expression of med genes is proportional to gene
dosage. Hence, gene amplification may simply be a route to
increase med expression, and assure that high amounts of MED
activity, with the correct kinetics, are produced rapidly during a
critical developmental time point.
Is Cr-med-2 a pseudogene?
The failure of Cr-med-2 to complement a C. elegans med-
1,2() double mutant, and the absence of a significant number
of SKN-1 sites in its putative promoter, suggest that Cr-med-2
may be a pseudogene. A similar situation exists with the C.
elegans GATA factor gene elt-2: A 5V truncated coding region,
called elt-4, is found several kb upstream of its apparent full-
size paralog, elt-2 (Fukushige et al., 2003). ELT-2 is essential
for the formation of the intestine and is known to function as a
transcriptional activator (Fukushige et al., 1998, 2003). In
contrast, while expression of elt-4 has been demonstrated, there
appears to be no phenotypic consequence to its deletion, nor
can any biochemical function be assigned to the ELT-4 protein
either in vitro or when expressed in yeast (Fukushige et al.,
2003). There is precedent, therefore, for duplication and
retention of a fragment of GATA family gene despite any
detectable function. As none of our assays directly addressed
function or expression of only Cr-med-2 in C. remanei, a rolefor Cr-MED-2 distinct from early mesendoderm specification
cannot be ruled out.
Differential requirements for the MEDs in MS and E fates
Our studies have shown that while the MED genes function
in the specification of MS and E, there are different
requirements for the MEDs in each of these sister cells. All
embryos fail to specify MS in C. elegans med-1,2(), while
only 42% fail to make endoderm. Clearly, the MEDs are
critical for MS but dispensable much of the time for E fate.
Indeed, we have shown that there are at least three other inputs
into E specification: the Wnt effector POP-1, the Caudal-like
homeodomain protein PAL-1, and maternal SKN-1 itself
(Maduro and Rothman, 2002; Maduro et al., 2005b).
The critical requirement for MED function in MS rather
than E is also apparent in the rescuing abilities of the various
med homologs. With the exception of Cr-med-2, rescue of E
occurred in more transgenic animals than did complete rescue
of MS. As there are other inputs into endoderm specification,
this is perhaps to be expected. Recent work has shown that the
MED target genes in MS and E are largely nonoverlapping
(that is, they function in MS or E but not both) (Broitman-
Maduro et al., 2005). The ability of most of the med homologs
to rescue the lethality of a C. elegans med-1,2() strain to
viability implies that the entire suite of MED target genes can
be activated by the Cb-MED and Cr-MED regulators (except
Cr-MED-2/7). The reduced ability of these interspecific med
homologs to fully rescue the MS defect suggests that there are
at least some MS target genes that are exquisitely sensitive to
stochastic differences in the levels or function of the transgenic
MED proteins. Whether this arises from changes in recognition
of cis-regulatory sites by the MEDs, or other aspects of MED
expression and function, remains to be elucidated.
Why are all 11 med genes intronless?
In addition to the amino acid similarity and functional
conservation, the med genes share one other characteristic, that
of intronless coding regions. For the purposes of function, the
presence of introns does not appear to be detrimental: both a
Cr-med-1::GFP::MED-1 fusion and a Ce-med-1:GFP::MED-1
fusion can each rescue Ce-med-1,2() embryos, despite the
presence of three introns in the GFP coding region (A. Fire,
personal communication), and the fact that the inserted
sequences result in a transgene mRNA that is approximately
twice as long as the endogenous med transcripts. However, an
effect operating at the level of a single gene in a chromosomal
context, as opposed to a multicopy array, cannot be ruled out.
The meds appear to be unusual in their intronless gene
structure, as such genes are comparatively rare in C. elegans.
Among GATA factors in C. elegans, they are the only
intronless ones. A recent study has determined that while
13% of annotated human genes and approximately 18% of
Drosophila genes are intronless, only 3% of C. elegans genes
lack introns (Sakharkar and Kangueane, 2004; Sakharkar et al.,
2005). Some gene families, such as G-protein coupled
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perhaps because many copies have arisen by retroposition
(Gentles and Karlin, 1999; Roy and Gilbert, 2005); however,
C. elegans appears to be the exception in this instance, as the
majority of its GPCR genes do possess introns (Gentles and
Karlin, 1999). The presence of conserved SKN-1 sites outside
the med coding regions suggests that, with the exception of Cr-
med-2, the meds have undergone amplification by a process
that duplicates both the transcribed and flanking sequences,
rather than a mechanism that requires an mRNA intermediate.
Alternatively, a mechanism may exist that strongly selects
against acquisition of introns in med genes. For example, gene
conversion events among the meds could account for both the
lack of introns and the apparent coevolution of med sequences
within each species. Identification of more med homologs from
other species, or demonstration of a gene conversion mecha-
nism in C. elegans, may help resolve this question.
A conserved early mesendoderm network
The foregoing studies provide strong evidence that despite
the divergence among the C. elegans and C. remanei med
genes, they are activated in the same spatiotemporal pattern
(i.e. immediately downstream of SKN-1), and most of these
genes have retained the ability to activate the same sets of
target genes as determined by inter-species rescue. Hence,
while the med gene family has undergone much duplication in
C. remanei, most of the paralogs still function in the context of
a similar gene regulatory network that specifies the MS and E
fates (Fig. 1). This suggests that despite tens of millions of
years of evolution, the mechanism that specifies early
mesendoderm fates in Caenorhabditis involves deployment
of the same sets of genes. This is perhaps not that surprising, as
more distant nematodes, such as Halicephalobus (Panagrolai-
midae) and Rhabditophanes (Rhabditidae), show very similar
early development as C. elegans in the establishment and
position of the early founder cells, including MS and E
(Borgonie et al., 2000). It will therefore be of interest to
identify more med homologs from more distant species, and
begin a directed approach to structure–function analysis of the
MED class of zinc finger proteins.
Note added in proof
We have recently been made aware of two additional
candidate C. briggsae med-like genes: Wormbase CDG00186
(an apparent pseudogene) and CDG15489.
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